SALICYLATE IN ASPIRIN: Health benefits and risk
1.Salicylates have been available since the early 1900s. 2.Salicylates have been derived from the willow tree bark. 3.The…
Promising Approaches in HIV Cure Research: Targeting Latent Reservoirs
Targeting molecules involved in the establishment maintenance, and reactivation of the latent HIV reservoir is indeed a promising…
ANTINEOPLASTIC AGENT : A Comprehensive Guide
The antineoplastic agents or anticancer drugs represent a large and diverse class of medications. Cancer is a disease…
Dr. Reddy’s launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Proud to announce the launch of Toripalimab in India, the first and only immuno-oncology drug approved by various…
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
Ultromics’ breakthrough device for cardiac amyloidosis gets FDA nod
EchoGo® Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an…
Cefepime – Enmetazobactam Antibiotic Launch | Orchid Pharma & Cipla Partnership
Orchid Pharma Limited, (‘Orchid Pharma’) based in Chennai, India, the only Indian pharmaceutical company to have ever invented…
Indoco Remedies receives final ANDA approval from USFDA for Varenicline Tablets, 0.5 mg and 1 mg
Indoco Remedies Ltd. announced the final approval of the Company’s Abbreviated NewDrug Application (ANDA) for Varenicline Tablets, 0.5…
“Animal Health Merger: SeQuent Scientific and Viyash Lifesciences Create Global Leader | Animal Health Insights”
SeQuent Scientific and Viyash Lifesciences Announce Strategic Merger to Create a Global AnimalHealth Leader with End-to-End Integrated Capabilities…
Dr. Reddy’s Laboratories received Voluntary Licence from Gilead to make the latest generation HIV drug
Dr. Reddy’s Laboratories received Voluntary Licence from Gilead to make the latest generation HIV drug, lenacapavir, accessible to…